Anesthetic Ketamine Impairs Rats' Recall of Previous Information
Antonios Boultadakis, Nikolaos Pitsikas
Anesthesiology June 1, 2011 DOI: 10.1097/aln.0b013e318219524e (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled animal experiment Peer reviewed |
|---|---|
| Population | Rats |
| Intervention | Ketamine |
| Dose | Ketamine 100 mg/kg intraperitoneally (anesthetic) and 3 mg/kg intraperitoneally (subanesthetic); L-NAME 1, 3, and 10 mg/kg intraperitoneally |
| Measures | Novel object recognition test (discrimination index) |
| Topics | Esketamine Ketamine |
| Key findings | Anesthetic ketamine (100 mg/kg) impaired rats' recognition memory, lowering the discrimination index from 0.415 (saline) to 0.128, whereas a subanesthetic dose (3 mg/kg) did not. L-NAME at 1 and 3 mg/kg reversed the deficit (index 0.427 and 0.478), but 10 mg/kg did not. The authors conclude that anesthetic ketamine impairs posttraining memory storage and/or retrieval and that a nitric oxide component modulates these effects. |
Abstract
Background: There is poor experimental evidence concerning the effects of anesthetic doses of the noncompetitive N-methyl-D-aspartate receptor antagonist ketamine on rodents' memory abilities. The current study was designed (1) to investigate the consequences of posttraining administration of anesthetic ketamine (100 mg/kg intraperitoneally) on rats' recognition memory and (2) to evaluate the ability of the nitric oxide synthase inhibitor N-nitro-L-arginine methylester (L-NAME; 1, 3, and 10 mg/kg intraperitoneally) to counteract the expected behavioral deficits produced by anesthetic ketamine. Finally, in an attempt to clarify if the expected memory impairments produced by anesthetic ketamine were related to the anesthesia, we also tested the effects of a subanesthetic dose of it (3 mg/kg intraperitoneally) on rats' recognition memory.
Methods: The novel object recognition test, a procedure assessing recognition memory in rats, was selected.
Results: Posttraining administration of anesthetic (but not of subanesthetic) ketamine disrupted rats' performance in the novel object recognition paradigm. The discrimination index (D) was decreased by ketamine from 0.415 (using saline) to 0.128, thus indicating that the anesthetic dose of ketamine impaired recognition memory. L-NAME (1-3, but not 10, mg/kg) reversed this memory deficit produced by ketamine; the D index of 0.128 using ketamine treatment was increased by 1 and 3 mg/kg L-NAME to 0.427 and 0.478, respectively.
Conclusions: The current results indicate that anesthetic ketamine impaired rats' posttraining memory components (storage and/or retrieval of information) and that a nitric oxide component modulates its behavioral effects.
Comparable studies
Other preclinical and animal studies on ketamine, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists Rats | 2010 | Observational study | |
| Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Conscious rats | 1997 | Dose-response study with microdialysis and behavioral testing | |
| NMDAR inhibition-independent antidepressant actions of ketamine metabolites Mice | 2016 | Preclinical study | |
| The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate Spinal neurons in decerebrate or pentobarbitone-anaesthetized cats and rats | 1983 | Experimental study | |
| R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects Mice | 2015 | Experimental study |
Citations in the library
Cited by 5
- Nitrous Oxide, a Rapid Antidepressant, Has Ketamine-like Effects on Excitatory Transmission in Adult Hippocampus Biological Psychiatry June 1, 2022
- Ketamine acutely impairs memory consolidation and repeated exposure promotes stereotyped behavior without changing anxiety- and aggression-like parameters in adult zebrafish. Physiology & Behavior January 18, 2022
- Episodic-like memory impairment induced by sub-anaesthetic doses of ketamine. Behavioural Brain Research February 1, 2019
- Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy. Frontiers in Psychiatry 2015
- NMDA receptor antagonists distort visual grouping in rats performing a modified two-choice visual discrimination task. Psychopharmacology October 1, 2013
Cites 5
- Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Archives of General Psychiatry March 1, 1994
- Recent advances in the phencyclidine model of schizophrenia American Journal of Psychiatry October 1, 1991
- Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex Journal of Neuroscience April 15, 1997
- Revising a Dogma: Ketamine for Patients with Neurological Injury? Anesthesia & Analgesia July 12, 2005
- Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits. Journal of Neuroscience May 14, 2008